How AI That Powers Chatbots and Search Queries Could Discover New Drugs

Natural language processing algorithms like the ones used in Google searches and OpenAI’s ChatGPT promise to slash the time required to bring medications to market Original Article: https://www.wsj.com/articles/how-ai-that-powers-chatbots-and-search-queries-could-discover-new-drugs-11670428795?mod=foesummaries In their search for new disease-fighting medicines, drug makers have long employed a laborious trial-and-error process to identify the right compounds. But what if artificial intelligence could…

Ainnocence and Sino Biological Partner to Offer Next-Generation CRO Antibody Development Services

Beijing, China – March 22, 2022 – Ainnocence, Inc. of San Jose, California, is pleased to announce a CRO services partnership with Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services. Under the terms of this partnership, Sino…

Ainnocence Launches Self-Evolving, Multi-Objective AI Drug Discovery Platform

SAN DIEGO, California., June 13, 2022 /PRNewswire/ — Ainnocence, a global biotech startup on a mission to accelerate drug discovery using a fast, self-evolving AI drug design platform, launched today at the 2022 BIO International Convention (booth 4001). Founded by a versatile team of biomedical scientists and computer scientists, Ainnocence provides small- and large-molecule design…

AI-Designed Mutation-Resistant Broad Neutralization Antibodies Against Multiple SARS-CoV-2 Strains

Artificial intelligence has the advantage of allowing for the analysis of big and ever-changing data such as the dynamic genome information of a constantly evolving virus. In this study, we have applied AI technologies in the computational design of broad neutralization antibodies against over 1300 different historical SARS-CoV-2 strains with very small computational cost. The…